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Abstract. Furocoumarins are natural photosensitizing drugs used in PUVA photochemotherapy and in
photopheresis. Their therapeutic effectiveness is connected to the lesions they induce to various cell compo-
nents, membranes, ribosomes, mitochondria, and in particular to DNA, damaged by formation of monofunc-
tional adducts and of inter-strand cross-links (ISC). ISC represent a severe damage, mainly correlated to the
main side effects observed in photochemotherapy, skin phototoxicity and genotoxicity. Searching for new
monofunctional derivatives, two tetramethylfuroquinolinones, 1,4,6,8-tetramethyl-2H-furo[2,3-h]quinolin-2-
one (FQ) and 4,6,8,9-tetramethyl-2H-furo[2,3-h]-quinolin-2-one (HFQ) were studied. Both compounds are very
active; however while FQ produced many chromosomal aberrations and strong skin erythemas, HFQ practi-
cally did not induce such side effects. FQ and HFQ formed high levels of monoadducts but no ISC in DNA,
but both provoked many DNA-protein cross-links (DPC). FQ induced these lesions by a biphotonic reaction:
at first a furan-side monoadduct is formed, which is then converted into a DPC; thus the FQ molecule seemed
to form the bridge between DNA and proteins. HFQ formed DPC by a single step (DPC at zero length, like
UVC). For these features, HFQ appears to be the first molecule belonging to a new class of active but not
phototoxic drugs for photomedicine.
1. INTRODUCTION
Furocoumarins are active photosensitizing drugs
widely used in photomedicine [1], in research on the
structure of various biological macromolecules [2] and
on DNA repair [3]. Some of them are natural compounds
present in several plants, such as Psoralea corylifolia,
Amni Majus and Angelica Archangelica (see Figure 1 for
the molecular structure of some natural derivatives).





























Figure 1. Molecular structure of some natural occurring
furocoumarins.
from centuries: in fact, ancient Egyptian and Indian
physicians used extracts of leaves, seeds or roots from
plants containing furocoumarins for the cure of vi-
tiligo since thousands years BC [4]. These preparations
were applied on the skin or ingested and the patient
was then exposed to sunlight. In seventy years, pho-
tochemotherapy PUVA (psoralen + UVA) has been intro-
duced: 8-methoxypsoralen (8-MOP), the active principle
presented in Amni Majus, was administered orally; two
hours later the skin area to be cured was exposed to
UVA light (320–400 nm) [5]. PUVA is effective against
various skin diseases, such as vitiligo, psoriasis, alope-
cia aerata, atopic dermatitis, mycosis fungoides, etc. [1].
More recently the extracorporeal photochemotherapy
or photopheresis has been introduced [6]. According
to this therapy 8-MOP is administered orally; after two
hours about 0.5 litres of blood were taken out by the
patient, the lymphocytes were isolated and exposed to
UVA light. Then, lymphocytes were returned back to
the patient. This treatment is practically an auto vac-
cination against the same lymphocytes; because they
are specific for the disease, a selective immuno modu-
lation is induced, without dangers of opportunistic in-
fections. FDA approved photopheresis for the cure of
T-cell lymphoma but it is effective against various au-
toimmune diseases and in the prevention of rejection
in organ transplantation [7].
By UVA irradiation furocoumarins induce various le-
sions in a living cell: damage to unsatured fatty acids
and lecithins of membranes [8, 9] and to ribosomes
[10,11]. However the main damage is provoked in DNA
[12]. Linear furocoumarins (psoralens) have two reac-
tive sites in their molecule, the double bonds at 3,4 po-
sitions at pyron ring and at 4′,5′ at furan one. In the
dark furocoumarins intercalate into base pairs of DNA
without significant consequences; however, by light ac-
tivation they react with pyrimidine bases via a C4-
cycloaddition, forming covalent monoadducts (MA) en-
gaging 3,4 (pyron side) or 4′,5′ (furan side) positions.
Furan side monoadducts can absorb the UVA light and
react further with a second pyridine bases, thus form-
ing a covalent bridge between the two DNA strands
(inter-strand cross-links, ISC) [13]. The formation of
such bifunctional adducts represents a severe damage,
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which is regarded as mainly responsible for the side
effects of PUVA therapy, the induction of skin erythe-
mas [1] and for genotoxicity [14]. Thus, with the aim
to obtain furocoumarins having a reduced toxicity, var-
ious authors prepared and studied several monofunc-
tional derivatives, incapable of forming ISC. A mono-
functional furocoumarin can be obtained by several
ways: blocking one of its two photoreactive sites by in-
sertion of a suitable group, as for 3-carbethoxypsoralen
[15], or by cumulating a fourth nucleus, e.g., the pyri-
dopsoralens having a pyridine condensed at 3,4 posi-
tions [16] and benzopsoralens in which the fourth nu-
cleus is a benzenic one at 4′,5′ position [17]. We also
studied several new angelicin derivatives, which, for
the geometric parameters of their angular molecular
structure, can hardly induce ISC [18]. Thus, we obtained
various active and interesting angelicins; the best one
is certainly 4,6,4′-trimethylangelicin [18]. Recently we
also studied some homologues drugs which can be con-
sidered angelicin isosters; the most interesting com-
pounds are two angular furoquinolinones, FQ (1,4,6,8-
tetramethyl-2H-furo[2,3-h]quinolin-2-one, according to
JUPAC) [19] and HFQ (4,6,8,9-tetramethyl-2H-furo[2,3-
h]-quinolin-2-one) having a nitrogen atom replacing the
oxygen at 1 position; the main difference between these
two derivatives is the presence or the absence of a















Figure 2. Molecular structure of the tetramethylfuroquino-
linones.
2. MAIN PROPERTIES OF FUROQUINOLINONES
Both FQ and HFQ are characterized by a strong photo-
sensitizing activity. In fact, upon UVA irradiation, both
compounds induce a dramatic killing effect in CHO
cells, even when they were employed in very mild exper-
imental conditions. As we can see in Figure 3, there are
not significant differences between the survival curves
generated by FQ and HFQ. On the contrary, 8-MOP,
tested at a double concentration, induced a very small
effect. However, studying their capacity of inducing ery-
themas on the skin, we obtained a surprising result:
while FQ appeared to be as phototoxic as 8-MOP, HFQ
was nearly inactive. The threshold doses for erythema
induction, that is the minimum amount of drug and
of UVA light necessary to induce a barely visible ery-
thema on albino guinea-pig skin, are shown in Table 1.
FQ is only slightly more active than 8-MOP, while HFQ
is poorly effective.


















Figure 3. Clonal growth of CHO: cells were exposed to UVA
light in the presence of the drug (FQ and HFQ 2.3µM; 8-MOP
4.6µM) and then the capacity of cells of forming clones was
assayed.
Table 1. Threshold doses for erythemas induction on guinea
pig skin.
Compounds were applied on the skin as a 0.1% methanolic
solution and the skin was exposed to UVA light. The ani-
mals were then kept in the dark and observed for 3 days.
The dose unit is a parameter proportional to the activity,
defined as follows: 1/((µM · cm−2)(kJ ·m−2)) in which
µM·cm−2 is the furocoumarin amount applied to a cm2
of the skin and kJ·m−2 is the UVA dose.
Compound µM·cm−2 kJ·m−2 Dose Relative
unit ×10−2 activity
8-MOP 4.6 5 4.3 1
FQ 3.3 5 6 1.39
HFQ 20 25 0.2 0.04
The skin phototoxicity is the furocoumarin photo-
sensitising effect known from the longest time; in fact,
in the past, a non-skin phototoxic compound was re-
garded as totally inactive. At present we don’t know
what is the mechanism of erythema formation, even
if several hypothesis have been suggested: the gener-
ation of active species of oxygen, such as singlet oxy-
gen [20] or the ISC induction [1]. However until now, all
experimental data bore out neither of these hypothe-
ses. Nevertheless, in 1990, Ortel et al., using the so-
called double irradiation protocol, observed that the
erythemas on human skin generated by 8-MOP are in-
duced by a two steps reaction, as happen for ISC for-
mation [21]. It is well known that furocoumarins in-
duce ISC by the sequential absorption of two photons;
the first one yields to the formation of a furan side
monoadduct and the second photon converts it into
an inter-strand cross-link. The double-irradiation is an
important method which allows a selectively study of
the consequence of MA and ISC [19]. After a small
UVA dose, which provokes mainly the formation of
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monoadducts, the unbound furocoumarin molecules
are removed by washing and the biological system is
exposed again to the light. During the second irradia-
tion step some monoadducts can be converted into ISC
without an increase of the total number of the lesions.
3. FUROCOUMARINS INDUCE DNA-PROTEIN
CROSS-LINKS
On the bases of these data, we suggested that furo-
coumarins could undergo to another kind of biphotonic
reaction; because they can link covalently both to DNA
and to proteins [22], we supposed they can form DNA-
protein cross-links (DPC). Since it is impossible to de-
tect such lesions in simplified systems, we studied them
in whole mammalian cells, using alkaline elution [19].
Thus, we observed that linear furocoumarins induce
DPC, while angular ones, like angelicin derivatives, are
less effective [23]. Therefore, the study of the mecha-
nism and of the consequence of DPC appeared to be
very difficult, because linear furocoumarins form both
DPC and ISC.
The solution of this problem was found with FQ and
HFQ, the two furoquinolinones above mentioned. Actu-
ally, as reported in Table 2 and contrary to 8-MOP, both
compounds are incapable of inducing ISC, while they
can form DPC to noticeable extents.
Table 2. Damage induced in DNA (8-MOP = 1). The data
are expressed as relative activity in comparison to 8-MOP.
(a) detected in CHO cells by alkaline elution; (b) estimated
in vitro in the photoreaction with calf thymus DNA.
Compound ISC(a) DNA binding(b) DPC(a)
HFQ 0.01 5.70 2.40
FQ 0.01 9.56 8.50
8-MOP 1.0 1.0 1.0
4. MECHANISMS OF DPC FORMATION
Therefore, we studied the formation of DPC and
some their biological consequences using FQ and HFQ.
At first, we studied DPC formation in CHO cells us-
ing alkaline elution and the above mentioned double-
irradiation protocol [19]. Figure 4 shows the results
thus obtained. Furan-side monoadducts induced by FQ
can produce a number of DPC, with a gradual increase
of their amount according to the UVA dose delivered in
the second step. On the contrary, with HFQ, after the
second step the DPC number remained practically un-
changed.
Therefore, it is evident that FQ induces a number of
DPC by a two step mechanism, while HFQ can form this
lesion only by a one step reaction. Consequently, we
can suppose that FQ induces a new diadduct in which
its molecule forms the bridge between DNA and protein
(DPC at length greater than zero); on the contrary, HFQ





























Total UVA dose ( kJ·m−2)
FQ HFQ
First step Second step
Figure 4. DPC formation in CHO cells by the double-
irradiation method: CHO cells were exposed at a first ir-
radiation step (0.06 KJ·m−2) in the presence of 2.3µM FQ
or HFQ. The cells were washed and then submitted to the
second step, carried out with two different UVA dose. DPC
















Figure 5. Scheme of the methods used for DPC detection in
vitro. (1) Single irradiation: aqueous solutions of DNA, hi-
stones and the drug (20µM) were mixed together, and the
mixture was exposed to UVA light (15 kJ·m−2); DNA was
extracted and determined by spectrophotometric determi-
nation. (2) Double irradiation: an aqueous solution of calf
thymus DNA was exposed to 10 kJ·m−2 in the presence of
the drug (20µM) and then submitted to dialysis overnight
against PBS; histones from calf thymus were added to the
solution which was then irradiated again (15 kJ·m−2); DNA
was extracted and its amount determined as above. To
check the adduct formation with proteins, histones were
submitted to the first irradiation step: in this case after dial-
ysis, DNA was added and the solution was irradiated for the
second time and processed as above.
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To confirm these data we carried out some exper-
iments in vitro; Figure 5 shows the protocols used,
by single and double irradiation. In the single irradia-
tion method, DNA and histones from calf thymus were
mixed together thus obtaining a nucleoprotein com-
plex, which was exposed, to UVA light in the pres-
ence of furocoumarins. Then DNA was extracted and
its amount determined. Because the formation of DPC
reduced the amount of the extractable DNA, we can
have an evaluation of their amount. This protocol
was also modified according to the double-irradiation
method: actually, we can submit to the first step DNA
or histones. After the first irradiation the free furo-
coumarin molecules were removed by dialysis, and the
second macromolecule, histones or DNA respectively,
was added to the mixture. Then it was submitted to
the second UVA exposure followed by DNA extraction.
Figure 6 shows the results obtained with furoquinoli-
nones and 8-MOP using these procedures. These data
are consistent with those obtained in vivo; actually, the
different mechanisms of DPC formation by FQ and HFQ
were confirmed by these experiments. In fact, with FQ
(and 8-MOP too) using the double-irradiation protocol
and treating DNA in the first step we obtained DPC
to an extent very close to that achieved by irradiat-
ing the pre-formed nucleoprotein complex. On the con-
trary, HFQ always yielded very poor amounts of DPC by
the two steps protocol. Moreover, using histones in the
first step we obtained completely negative results. This
means that the biphotonic reaction involving FQ (or 8-

























Figure 6. (1) DNA: double-irradiation procedure in which
DNA was submitted to the first irradiation step. (2) Histones:
double-irradiation procedure in which histones were sub-
mitted to the first irradiation step. (3) Mixture: according
to single irradiation procedure DNA, histones and the drug
were submitted together to a single UVA light exposure.
The behaviour of HFQ can be explained by the low ab-
sorption of its furan side monoadducts at 360 nm, that
is the maximum of emission of the lamp used in our
experiments [24].
5. BIOLOGICAL CONSEQUENCES OF DPC
FORMATION
As a first approach, we detected the formation of
double-strand breaks (DSB; DNA fragmentation) by neu-
tral elution [25]; CHO cells were submitted to sensiti-
zation with increasing UVA doses and then they were
incubated for 24 hours before testing DNA damage. Fig-
ure 7 shows the results thus obtained. FQ induced a
very large DNA fragmentation even at very low UVA
doses, much more pronounced than 8-MOP; on the con-
trary, HFQ appeared to be ineffective. We must realize
that DNA fragmentation is not provoked by the photo-
chemical reaction, because it can be observed only after
a suitable incubation time, performed after the treat-
ment, at least 12 hours (data not shown). This means it
is due to an enzymatic DNA processing that takes place




























0.0 0.2 0.4 0.6




Figure 7. DSB formation by sensitisation with FQ, HFQ
(2.3µM) and 8-MOP (4.6µM). CHO cells were exposed to in-
creasing UVA doses in the presence of the drug and then
incubated for 24 hours. DSB were detected by neutral elu-
tion [25].
This behaviour is consistent with the data obtained
studying the capacity of furoquinolinones of forming
chromosomal aberrations (see Table 3). Actually FQ in-
duced a lot of aberrations, while HFQ gave values very
close to the controls.
To have direct information of the consequences in-
duced by DPC at length greater than zero formed by
FQ, we carried out some experiments with the double-
irradiation protocol. Because both FQ and HFQ cannot
form ISC at all, we can only detect the biological effect of
the formation of DPC. Figure 8 shows the data obtained
with this procedure in CHO cells testing the formation
of chromosomal aberrations. We can see that their num-
ber increases after the second irradiation step; because
FQ with this mechanism induces only DPC, but not ISC,
this result tells us that DPC are mainly responsible of FQ
genotoxicity. On the contrary, HFQ was practically inac-
tive. To establish this assumption, we plotted the num-
ber of aberrations scored with FQ against DPC amounts
Vol. 1 Photochemical and photobiological properties . . . 5
Table 3. Chromosomal aberrations in CHO cells. After treat-
ment, CHO cells were incubated for 24 hours at 37 ◦ in









None 0 2 0.8
(controls)
8-MOP 4.6 1.65 32.5
FQ 2.3 0.12 75.6





















Total dose of UVA ( kJ· m−2)
HFQ FQ
First step Second step
Figure 8. Chromosomal aberrations induced by the double-
irradiation protocol. The first step was carried out using
a 2.3µM concentration. After several washing, CHO cells
were irradiated further with different UVA doses. The aber-
ration frequency was determined after 24 hours of incuba-
tion.
formed in the same experimental conditions. A straight
line was obtained, with a good linear relationship (data
not shown).
Using the same protocol, we also detected the lethal-
ity of DPC greater than zero of FQ in CHO cells; as
expected, with HFQ the surviving fraction obtained af-
ter the first irradiation was not further decreased sig-
nificantly by the second step. As expected, during the
second irradiation step DPC formed by FQ strongly re-
duced the survival, according to the UVA dose, with an
evident killing effect (see Figure 9).
6. DISCUSSION
FQ and HFQ induce the same kinds of damages into
DNA, roughly to the same order of magnitude (mainly
monofunctional adducts and DPC, but no ISC); in com-
parison with 8-MOP both compounds are much more ef-
fective. This behaviour is consistent with the very high


















Figure 9. Clonal growth studied by the double-irradiation
protocol: CHO cells were exposed to the first irradiation step
(0.06 KJ·m−2) in the presence of 2.3µM FQ or HFQ. The cells
were washed and submitted to the second irradiation step.
Clonal growth was then determined.
CHO cells; in this test, 8-MOP, despite its capacity of
forming ISC, appeared to be poorly active, even if as-
sayed in more severe conditions. Using the double-
irradiation method we observed that FQ could induce a
number of DPC by a two steps mechanism; on the con-
trary, HFQ can form this lesion only by a single step
one. Because both drugs cannot form ISC, we studied
the antiproliferative activity of DPC using the double-
irradiation method; as expected, the second irradiation
step was ineffective with HFQ, but, on the contrary, FQ
induced a strong reduction of the survival.
It is well known that the formation of ISC by furo-
coumarins requires the sequential absorption of two
photons. We found that FQ induced DPC by a similar
process. Conversely, DPC formation by HFQ occurs cer-
tainly with the absorption of a single photon; therefore
they are certainly cross-links at zero length, like to that
formed by UVC. In conclusion, we could suppose DPC
formed by the two drugs might be different. At present
this is only a working hypothesis, but it seems to be con-
sistent with the data we obtained studying the repair
and the genotoxicity of such lesions. In fact, following
the formation of DSB in DNA by incubating in growth
medium the sensitized CHO cells, we observed with FQ
a very high DNA fragmentation; with HFQ practically no
DSB were formed. DSB are clearly not induced by a pho-
tochemical reaction but by enzymatic processes occur-
ring during cell incubation after the treatment. 8-MOP,
used as a reference, formed significant amounts of DSB
even if to a much lower extent in comparison with FQ.
We obtained the same picture studying the formation
of chromosomal aberrations. FQ yielded a lot of aber-
rations and their number increased with the second ir-
radiation step: this probably means they are produced
by DPC induction. Even in this test, HFQ appeared to be
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practically inactive.
Checking the classic effect induced by furo-
coumarins, i.e., the formation of skin erythemas, we
found again the same situation: FQ is almost as active
as 8-MOP, while HFQ only provoked weak erythemas in
more severe experimental conditions.
Therefore, DPC formed by the furoquinolinones ap-
pear to be very different, at least on the bases of their
dissimilar mechanism of formation and of their bio-
logical consequences. As stated before, certainly DPC
formed by HFQ are at zero length. DPC induction by FQ
represents a more complicated process. Actually, even
if these DPC are formed by a double-step mechanism
like ISC, thus suggesting they are cross-links at length
greater than zero, at present we have no direct evi-
dences that the FQ molecule is really a physical part of
the cross-links between the two macromolecules. How-
ever this seems to be much more than an interesting
hypothesis, because it is supported also by some data
already published [25].
Finally, HFQ seems to be an interesting drug for pho-
tomedicine. In fact, the data regarding its activity on
mammalian cells together with its very low skin photo-
toxicity and genotoxicity suggest that it could be a new
promising agent for photochemotherapy.
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